共 81 条
TNF-Induced Interstitial Lung Disease in a Murine Arthritis Model: Accumulation of Activated Monocytes, Conventional Dendritic Cells, and CD21+/CD23- B Cell Follicles Is Prevented with Anti-TNF Therapy
被引:25
作者:
Wu, Emily K.
[1
,2
]
Henkes, Zoe I.
[2
]
McGowan, Brion
[2
]
Bell, Richard D.
[2
,3
]
Velez, Moises J.
[3
]
Livingstone, Alexandra M.
[1
,4
]
Ritchlin, Christopher T.
[5
]
Schwarz, Edward M.
[1
,2
,6
]
Rahimi, Homaira
[2
,7
]
机构:
[1] Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14642 USA
[2] Univ Rochester, Sch Med & Dent, Ctr Musculoskeletal Res, Rochester, NY 14642 USA
[3] Univ Rochester, Sch Med & Dent, Dept Pathol & Lab Med, Rochester, NY 14642 USA
[4] Univ Rochester, Sch Med & Dent, David H Smith Ctr Vaccine Biol & Immunol, Rochester, NY 14642 USA
[5] Univ Rochester, Sch Med & Dent, Dept Med, Allergy Immunol & Rheumatol, Rochester, NY 14642 USA
[6] Univ Rochester, Sch Med & Dent, Dept Orthopaed & Rehabil, Rochester, NY 14642 USA
[7] Univ Rochester, Sch Med & Dent, Dept Pediat, Rochester, NY 14642 USA
基金:
美国国家卫生研究院;
关键词:
TUMOR-NECROSIS-FACTOR;
TRANSGENIC MOUSE MODEL;
RHEUMATOID-ARTHRITIS;
FACTOR-ALPHA;
PULMONARY-FIBROSIS;
LYMPHATIC VESSELS;
MORTALITY;
PNEUMONIA;
MICE;
OVEREXPRESSION;
D O I:
10.4049/jimmunol.1900473
中图分类号:
R392 [医学免疫学];
Q939.91 [免疫学];
学科分类号:
100102 ;
摘要:
Interstitial lung disease (ILD) is a well-known extra-articular manifestation of rheumatoid arthritis (RA). RA-associated ILD (RA-ILD) exists on a wide spectrum, with variable levels of inflammatory and fibrotic activity, although all subtypes are regarded as irreversible pathologic conditions. In both articular and pulmonary manifestations, TNF is a significant pathogenic factor. Whereas anti-TNF therapy alleviates joint pathologic conditions, it exacerbates fibrotic RA-ILD. The TNF-transgenic (TNF-Tg) murine model of RA develops both inflammatory arthritis and an ILD that mimics a cellular nonspecific interstitial pneumonia pattern dominated by an interstitial accumulation of inflammatory cells with minimal-to-absent fibrosis. Given the model's potential to elucidate the genesis of inflammatory RA-ILD, we aim to achieve the following: 1) characterize the cellular accumulations in TNF-Tg lungs, and 2) assess the reversibility of inflammatory ILD following anti-TNF therapy known to resolve TNF-Tg inflammatory arthritis. TNF-Tg mice with established disease were randomized to anti-TNF or placebo therapy and evaluated with imaging, histology, and flow cytometric analyses, together with wild-type controls. Flow cytometry of TNF-Tg versus wildtype lungs revealed significant increases in activated monocytes, conventional dendritic cells, and CD21(+)/CD23(-) B cells that are phenotypically distinct from the B cells in inflamed nodes, which are known to accumulate in joint-draining lymph nodes. In contrast to human RA-ILD, anti-TNF treatment significantly alleviated both joint and lung inflammation. These results identify a potential role for activated monocytes, conventional dendritic cells, and CD21(+)/CD23(-) B cells in the genesis of RA-ILD, which exist in a previously unknown, reversible, prefibrotic stage of the disease.
引用
收藏
页码:2837 / 2849
页数:13
相关论文